glp 1 drugs examples GLP-1 Agonists: A Comprehensive Overview GLP-1 Agonists Explained: Definition, How
Description
"Myostatin/activin receptor ligands in muscle and the development status of attenuating drugs." Endocrine Reviews 43.2 (2022): 329-365
In the GLP-1 space, there are specific products FDA-approved for diabetes and specific products approved for weight loss
This blog is part of an ongoing series on A Brave New World: Therapeutic Area Deep Dives
That realization is pushing medicine toward a future of personalized obesity care, where treatment is tailored to an individuals specific biology rather than relying on one blockbuster drug for everyone
White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, Heller S, Mehta C, Nissen SE, Perez A, Wilson C, Zannad F
N.RussoA.PhillipsL.JonesK
